Visit Bioiberica at booth #4265 from October 30-31 to uncover opportunities for innovation in mobility, beauty-from-within and digestive health
Global life science company, Bioiberica, is returning to SupplySide West in Las Vegas next month to spotlight the latest cutting-edge clinical research behind its branded ingredients portfolio. This includes scientific studies uncovering the ‘glow effect’ of the company’s hyaluronic acid (HA) matrix ingredient Dermial® (60mg/day) for skin & beauty, and the role its native (undenatured) type II collagen Collavant® n2 (40mg/day) can play in supporting mobility in healthy individuals. The company is also showcasing a recent in vitro study of Mobilee® (80mg/day), the first-of-its-kind HA matrix, for muscle & joint health, Tendaxion (for tendon health at 520 mg/day), CSbioactive® (chondroitin sulfate) and DAOgest (4.2mg/serving/day), a premium diamine oxidase (DAO) enzyme ingredient for digestive health . Visitors to the exhibition’s Tasting Bar are invited to try exclusive prototype gummies formulated with HA matrix ingredients Dermial® and Mobilee®.
HA-matrix gummies for skin and muscle & joint health
With the global nutricosmetics market expected to grow at a CAGR of 8.34% over the period 2024-321, innovators in this space are invited to learn more about the latest clinical study supporting Bioiberica’s industry-first HA matrix, Dermial®. The research demonstrated that with daily supplementation of 60 mg/day, Dermial® can have a unique ‘glow’ effect on the skin, increasing brightness by 20% at six weeks and nearly 33% at twelve weeks.2 Attendees can also sample prototype gummies fortified with Dermial® for skin health and Mobilee® for muscle and joint health at the exhibition’s Tasting Bar. Alongside the gummies, Bioiberica will highlight in vitro research on Mobilee® which demonstrates the ingredient’s role in supporting muscle regeneration when combined with whey protein. Preliminary findings confirmed that the combination promoted an increase in muscle cell size and myogenic differentiation.3
Stepping up joint health innovation
Bioiberica is also set to present the findings of another clinical study for Collavant® n2, demonstrating the promise of this native type II collagen in supporting joint health. The study was carried out with healthy individuals and found that 40 mg/day of Collavant® n2 alleviates joint discomfort after exercise, indicating its potential to enhance the daily lives of consumers.4 Bioiberica’s experts will be on hand at the exhibition to delve into this cutting-edge research, and highlight what this ingredient’s recent obtained self-determined GRAS status means for its potential in the US mobility market.
Forging partnerships with an impact
“We’re excited to return to SupplySide West to meet with our new and long-standing partners,” comments Antonio Vendrell, Marketing & Communication Director at Bioiberica. “The US supplements market is booming, marking a key opportunity for innovation. We’re looking forward to presenting the latest cutting-edge science to support our branded ingredients portfolio, in line with our goal to empower the health evolution. We’ll also be taking the opportunity to spotlight our sustainability initiatives, as we continue to work towards the ambitious target of achieving climate neutrality by 2050.”
To learn more about Bioiberica’s science-backed nutraceutical ingredients, stop by booth #4265 at SupplySide West or visit: www.bioiberica.com.
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
